Lymphocyte Activation Gene-3 Blocker class drugs

1 result

Opdualag (nivolumab and relatlimab-rmbw)

(nivolumab and relatlimab-rmbw)
E.R. Squibb & Sons, L.L.C.
Usage: OPDUALAG™ is indicated for treating adult and pediatric patients aged 12 and older with unresectable or metastatic melanoma.